Skip to main content
. 2022 Nov 23;5(11):e2243597. doi: 10.1001/jamanetworkopen.2022.43597

Figure 3. Risk of Any Cardiovascular Event by Measure of Association Among Individuals Receiving Attention-Deficit/Hyperactivity Disorder Medication.

Figure 3.

CVD indicates cardiovascular disease; HR, hazard ratio; IRR, incidence rate ratio; OR, odds ratio.